MktsMarkets

Verrica Pharmaceuticals Inc.
NASDAQ: VRCAKey statistics
VRCA News
Stories mentioning VRCA from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 5,023 | 5,092 | 14,344 | 12,702 | 3,439 | 344.00 | (1,781) | 5,177 |
| Cost of Goods Sold | 700.00 | 800.00 | 400.00 | 700.00 | ||||
| Gross Profit | 2,739 | 4,477 | ||||||
| Operating Expenses | ||||||||
| Research & Development | 3,860 | 2,520 | 2,205 | 1,846 | 2,284 | 1,168 | 2,405 | 3,319 |
| Sales General & Admin | 9,989 | 8,117 | 9,403 | 8,852 | 8,848 | 9,878 | 16,083 | 16,522 |
| Total Operating Expenses | 14,738 | 12,284 | 12,717 | 11,192 | 11,569 | 11,754 | 18,923 | 20,383 |
| Operating Income (Loss) | (9,715) | (7,192) | 1,627 | 1,510 | (8,130) | (11,410) | (20,704) | (15,206) |
| Interest Income | 201.00 | 205.00 | 159.00 | 228.00 | 337.00 | 205.00 | 221.00 | 393.00 |
| Interest Expense | 2,368 | |||||||
| Other Expense | (8.00) | (2.00) | 0.00 | (1.00) | 0.00 | 0.00 | (1.00) | (5.00) |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (9,682) | (8,074) | (274.00) | 204.00 | (9,742) | (16,202) | (22,860) | (17,186) |
| Earnings Per Share (Basic) | (0.45) | (0.76) | (0.03) | 0.02 | (1.03) | (3.13) | (4.88) | (3.70) |
| Earnings Per Share (Diluted) | (0.45) | (0.76) | (0.03) | 0.02 | (1.03) | (3.13) | (4.88) | (3.70) |
| Weighted Average Shares Outstanding (Basic) | 21,305 | 10,652 | 9,490 | 9,488 | 9,484 | 5,181 | 4,681 | 4,650 |
| Weighted Average Shares Outstanding (Diluted) | 21,305 | 10,652 | 9,490 | 9,491 | 9,484 | 5,181 | 4,681 | 4,650 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About VRCA
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) is a stock listed on the Nasdaq Stock Market under the ticker symbol VRCA. It last traded at $3.42 (Oct 29, 2026, 4:00 PM ET), down 1.7% on the day. That gives Verrica Pharmaceuticals a market capitalisation of $63.2M.
Over the past 52 weeks VRCA has traded between $3.28 and $9.82.
Revenue for the quarter ended Mar 31, 2026 was $5.0M; a net loss of $9.7M. Revenue was up 46.1% from $3.4M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $5.0M | -$9.7M | -192.8% |
| Dec 31, 2025 | $5.1M | -$8.1M | -158.6% |
| Sep 30, 2025 | $14.3M | -$274.0K | -1.9% |
| Jun 30, 2025 | $12.7M | $204.0K | 1.6% |
From Verrica Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…